Wegovy Availability & UK Clinical Results | Cured
Cheapest Wegovy UK Price - From £69.00 Clinical Results
Get Wegovy at the cheapest UK price from £69 with £20 off your first order using code WEIGHTLOSSNEW.
Takes less than 2 minutes to complete 100% online
Treatment from £69.00
Check if you're eligible
Your BMI
26.8ⓘ Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
2.5mg
1 pen • 4 Weeks
£31.25 / Per Week
Your starting dose – designed to help your body adjust gently to treatment
5mg
1 pen • 4 Weeks
£39.75 / Per Week
First step up – builds on your progress as your body adapts to treatment
7.5mg
1 pen • 4 Weeks
£50.00 / Per Week
Mid-range dose – for continued progression and enhanced results
10mg
1 pen • 4 Weeks
£56.25 / Per Week
Higher strength dose – supports significant weight loss progress
12.5mg
1 pen • 4 Weeks
£62.50 / Per Week
Advanced dose – for patients requiring stronger therapeutic effect
15mg
1 pen • 4 Weeks
£66.75 / Per Week
Maximum dose – the highest available strength for optimal results
0.25mg
1 pen • 4 Weeks
£17.25 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
0.5mg
1 pen • 4 Weeks
£19.75 / Per Week
First step up – continues building tolerance for long-term success
1mg
1 pen • 4 Weeks
£24.75 / Per Week
Mid-range dose – where most patients start seeing meaningful results
1.7mg
1 pen • 4 Weeks
£37.25 / Per Week
Higher strength – supports accelerated weight loss progress
2.4mg
1 pen • 4 Weeks
£44.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
1.5mg
1 pen • 4 Weeks
£20.75 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
4mg
1 pen • 4 Weeks
£27.50 / Per Week
First step up – continues building tolerance for long-term success
9mg
1 pen • 4 Weeks
£35.00 / Per Week
Mid-range dose – where most patients start seeing meaningful results
25mg
1 pen • 4 Weeks
£49.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
Wegovy Availability & UK Clinical Weight Loss Results
Published on: June 03, 2026
Searching for accurate information on wegovy availability uk clinical results? Wegovy (semaglutide) is now consistently available at Cured Pharmacy from £79.00, following previous UK supply shortages. Clinical trial data demonstrates substantial weight loss outcomes when combined with lifestyle modifications, and our UK-registered prescribers can assess your suitability within minutes.
Current Wegovy Availability UK Status
Wegovy experienced significant supply constraints across the UK throughout 2022 and 2023 due to unprecedented global demand. The MHRA and manufacturer Novo Nordisk have since stabilised production, and Wegovy is now consistently available through registered UK pharmacies including Cured Pharmacy [1].
At Cured Pharmacy, we maintain regular stock of all Wegovy dose strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg). Our transparent pricing model shows costs upfront — from £79.00 per pen — before you complete your free clinical consultation. All prescriptions are issued by UK-registered prescribers following a thorough online assessment, typically completed in under three minutes.
Wegovy Clinical Trial Results: STEP Programme Data
The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provides the most comprehensive evidence for Wegovy's efficacy. In the landmark STEP 1 trial, adults with obesity who received once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2].
STEP 2 specifically examined patients with type 2 diabetes, demonstrating an average weight loss of 9.6% alongside improved glycaemic control [3]. Notably, 86.4% of participants in STEP 1 achieved at least 5% weight loss — the threshold associated with significant cardiometabolic health improvements — whilst 69.1% achieved 10% or greater weight reduction [2].
Long-Term Weight Maintenance Results
The STEP 4 trial examined weight maintenance after initial treatment. Participants who continued semaglutide maintained an average total weight loss of 17.4% from baseline at week 68, whilst those switched to placebo regained 6.9% [4]. This data suggests Wegovy supports sustained weight management when treatment continues alongside lifestyle modifications, subject to ongoing prescriber review.
How Wegovy Works: Semaglutide Mechanism
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone in your body. GLP-1 regulates appetite by acting on areas of the brain that control hunger signals, whilst also slowing gastric emptying to promote feelings of fullness [1].
Unlike older weight loss medications that work peripherally, semaglutide's central nervous system effects produce substantial appetite reduction. In clinical trials, participants reported decreased food cravings and reduced preoccupation with food — effects that contributed to the significant caloric deficit necessary for weight loss [2]. The once-weekly injection schedule improves adherence compared to daily treatments.
Wegovy Dosing Schedule and Treatment Timeline
Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising efficacy. Treatment begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, reaching the maintenance dose of 2.4mg by week 17 [1].
Clinical trial data shows most weight loss occurs during the first 60 weeks of treatment, with participants continuing to lose weight throughout this period when adherent to the prescribed regimen [2]. Your UK prescriber will monitor your progress and may adjust the escalation schedule if you experience tolerability issues. All dose changes require prescriber approval and cannot be self-adjusted.
What to Expect During Treatment
Most patients notice reduced appetite within the first few weeks of treatment, though maximum weight loss typically occurs gradually over 12-16 months. The STEP trials demonstrated that weight loss continues throughout the dose escalation phase and plateaus around week 60-68 [2]. Combining Wegovy with a reduced-calorie diet and increased physical activity produces optimal results, as demonstrated across all STEP trials.
Common Side Effects and Management Strategies
The most frequently reported side effects in STEP trials were gastrointestinal: nausea (44% vs 16% placebo), diarrhoea (31% vs 16%), vomiting (24% vs 6%), and constipation (24% vs 11%) [2]. These effects were predominantly mild to moderate in severity and typically diminished over time as patients adjusted to treatment.
Our clinical team at Cured Pharmacy, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), recommends several strategies to minimise side effects: eat smaller, more frequent meals; avoid high-fat foods; stay well-hydrated; and inject at consistent times. Most gastrointestinal symptoms resolve within 4-8 weeks. If side effects persist or worsen, contact your prescriber immediately — they may recommend slowing dose escalation or temporarily maintaining your current dose.
When to Seek Medical Advice
Discontinue Wegovy and seek immediate medical attention if you experience symptoms of pancreatitis (severe abdominal pain radiating to your back), signs of thyroid tumours (lump in neck, hoarseness, difficulty swallowing), or severe allergic reactions. Whilst rare, these serious adverse events were monitored throughout clinical trials [1]. Your prescriber will assess your individual risk factors during consultation, and Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma.
Wegovy Availability UK: Ordering from Cured Pharmacy
Ordering Wegovy through Cured Pharmacy is straightforward and fully compliant with UK regulations. Begin by completing our free online clinical assessment, which takes under three minutes and covers your medical history, current medications, and weight loss goals. A UK-registered prescriber reviews your assessment, typically within hours, and issues a prescription if clinically appropriate.
Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging. We offer competitive pricing with full transparency — you'll see the exact cost before completing your consultation. Our UK clinical team remains available at (+44) 116 4646009 for any questions throughout your treatment journey. All medications are genuine UK-licensed products sourced through regulated supply chains, never grey imports.
Scientific References
- Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
- Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment alongside diet and exercise modifications.
Trusted by thousands
Real people, real results
Jane L.
"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."
Ann-Marie
"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."
Sacha W.
"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."
Kimberly G.
"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"
Jennifer
"Great really helps cure those nasty habits can't wait for my next mounjaro pen."
How it Works?
Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026